Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes

被引:57
作者
Landis, Megan N. [1 ,2 ]
机构
[1] Univ Louisville, Sch Med, Dept Med Dermatol, Louisville, KY 40292 USA
[2] Dermatol & Skin Canc Ctr Southern Indiana, Corydon, IN 47112 USA
关键词
INFLAMMATORY-BOWEL-DISEASE; LOW-DOSE ISOTRETINOIN; ORAL ISOTRETINOIN; TRIGLYCERIDE LEVELS; RISK; DEPRESSION; EFFICACY; INTERMITTENT; VULGARIS; ANXIETY;
D O I
10.1007/s40257-020-00508-0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Acne vulgaris is the most common skin disease treated by dermatologists. It can be severe and result in permanent scars. Isotretinoin is the most effective treatment for acne and has the potential for long-term clearance. Prescribing and monitoring protocols can vary widely among prescribers. Recent studies, reports, and consensus statements help shed light on optimizing the use of isotretinoin for acne. A recent literature review is summarized in this article to help the practitioner optimize isotretinoin use for acne. The article outlines the advantages and disadvantages of standard, high-dose, and low-dose isotretinoin regimens; discusses the current status of controversies surrounding isotretinoin (including depression/suicide, pregnancy, and inflammatory bowel disease); reviews monitoring recommendations and treatment for hypertriglyceridemia and elevated transaminase levels; and discusses common adverse effects seen with isotretinoin, along with their treatment and prevention.
引用
收藏
页码:411 / 419
页数:9
相关论文
共 81 条
[1]   Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial [J].
Agarwal, Uma Shankar ;
Besarwal, Raj Kumar ;
Bhola, Kalyani .
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2011, 77 (06) :688-694
[2]   Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin [J].
Ahmad, Hesham M. .
DERMATOLOGIC THERAPY, 2015, 28 (03) :151-157
[3]   Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study [J].
Akman, Ayse ;
Durusoy, Cicek ;
Senturk, Meltem ;
Koc, Cilem Kaya ;
Soyturk, Durali ;
Alpsoy, Erkan .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 299 (10) :467-473
[4]   Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? [J].
Alcalay, J ;
Landau, M ;
Zucker, A .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2001, 12 (01) :9-12
[5]   Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study [J].
Alhusayen, Raed O. ;
Juurlink, David N. ;
Mamdani, Muhammad M. ;
Morrow, Richard L. ;
Shear, Neil H. ;
Dormuth, Colin R. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (04) :907-912
[6]   Low-dose isotretinoin in the treatment of acne vulgaris [J].
Amichai, B ;
Shemer, M ;
Grunwald, MH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) :644-646
[7]   Isotretinoin Is Not Associated With Inflammatory Bowel Disease: A Population-Based Case-Control Study [J].
Bernstein, Charles N. ;
Nugent, Zoann ;
Longobardi, Teresa ;
Blanchard, James F. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (11) :2774-2778
[8]   High-Dose Isotretinoin Treatment and the Rate of Retrial, Relapse, and Adverse Effects in Patients With Acne Vulgaris [J].
Blasiak, Rachel C. ;
Stamey, Christopher R. ;
Burkhart, Craig N. ;
Lugo-Somolinos, Aida ;
Morrell, Dean S. .
JAMA DERMATOLOGY, 2013, 149 (12) :1392-1398
[9]   Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris [J].
Boyraz, Nermin ;
Mustak, Pelin Kocyigit .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (10) :1265-1267
[10]  
Bozdag Kubra Eren, 2009, J Dermatolog Treat, V20, P293, DOI 10.1080/09546630903164909